Dentsu has promoted Greg Reilly, executive vice president, global customers, to president of its growing Dentsu Health business. Reilly, a member of Dentsu Health’s leadership team since its launch in April 2021, assumed the role last month.
Reilly is the de facto replacement for Dentsu Health’s global president, Matt McNally, who left the company in June to become CEO of Omnicom Health Group. McNally, in fact, was responsible for bringing Reilly to Dentsu Health in the first place: the two had previously worked together at Outcome Health and Publicis Health Media.
“He called me and said, ‘I’m going to do this thing at Dentsu, a different take on what other networks do. Do you want to join us? Reilly recalls.
This “different take” has taken hold over the past 20 months. Prior to Dentsu Health’s debut, Dentsu was the only large agency network that did not have a flagship health offering. Since then, the Dentsu Health team has drawn on the experience of some 2,000 people across Dentsu’s operations, including expert media (Carat), creative/interactive shops (360i) and customer experience/data management (Merkle).
“We’ve spent the last two years trying to craft a unique perspective based on what we think customers are looking for,” Reilly said.
Dentsu itself has evolved over the past few years from around 300 global brands to six. “We had a lot of health work, but [before Dentsu Health debuted] there was no consistent way for clients to understand all of these great capabilities and perspectives that we have in healthcare,” Reilly explained. “The question was, ‘How do you unlock the capabilities of this network if you’re a Merkle or Carat customer?'”
Reilly thinks Dentsu Health has answered that question. “It might not be the sexiest thing in the world, but it’s about having a very clear set of operating models,” he continued. “We have the scale of a global network, but we can add that layer of healthcare specialization. We can live in both worlds.
Reilly is well known in health media and agency circles. Prior to joining Dentsu Health, he served as Executive Vice President of CX and Industrial Sales at Outcome Health. In this role, he was a crucial member of the turnaround team tasked with rebuilding the business after a series of fraud allegations. Outcome was sold to PatientPoint in March 2021.
Reilly worked for Publicis Health Media from 2014 to 2019, rising to the role of Chief Client Officer. Prior to that, he worked for W2O Group and Razorfish Health, heading the Johnson & Johnson business of Razorfish.
As for what’s next, Dentsu Health is set to announce the addition of a new Executive Creative Director within the next week or two and has enlisted the expertise of Dentsu veterinarian Lynda Gordon in as Head of Health Data and Analytics.
“Obviously, responsible growth is always a priority,” Reilly said. “One of the things we talk about a lot is not losing sight of the fact that health is a human experience. There is data, technology and chatbots and these are extremely valuable as augmentations, but in everything we bring to customers and markets, we have to ask ourselves: “Does this meet the need health human? »